SuperworthShattuck Labs market cap STTK
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $551M
- Highest close in our data
- $2.4B
- Dec 2020
Shattuck Labs is worth $551M at the close on Oct 23, 2026, at $5.49 a share.
That is up 499% over the last year and down 32% over five years.
Its highest close in our data was $2.4B in Dec 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $551M | $234.8M | $755.7M | +160% |
| 2025 | $212M | $35.1M | $212M | +258% |
| 2024 | $59.2M | $47.7M | $512.6M | −80% |
| 2023 | $302.9M | $59.5M | $302.9M | +211% |
| 2022 | $97.5M | $86.5M | $319.4M | −73% |
| 2021 | $359.5M | $359.5M | $2.1B | −84% |
| 2020 | $2.2B | $1.4B | $2.4B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Shattuck Labs' size, closest first, today.
| Company | Market cap |
|---|---|
| STTKShattuck Labs | $551M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ARVNArvinas | $477.3M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Shattuck Labs
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.